Invictus Signs LOI For Cannabis Sales into Germany

INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV:GENE; OTC:IVITF; FRA:8IS1) is pleased to announce it has signed a non-binding Letter of Intent (“LOI”), executed on June 13, 2018, to sell dried cannabis to a German importer and distributor of medical cannabis (the “Importer”). The Company will initially commit to selling 1,000 kgs of dried cannabis flower per annum at a price of $6.50 per gram. The volumes and respective prices of dried cannabis flower for the second and consecutive years will be defined in a Definitive Offtake Agreement (the “Offtake Agreement”). The Importer, whose name will remain undisclosed until execution of the Offtake Agreement, combines a highly competitive business model with a vast distribution network of 20,000 pharmacies and a clear focus on product marketing and professional education. The Importer’s experienced management team previously led an international joint venture successfully to the final stage of the German tender for domestic cannabis production and … Continue reading

Veritas Inks Medical Cannabis Supply Agreement with Colombian Producer

Veritas Pharma (CSE:VRT) announced a new memorandum of understanding with Foliumed, a Colombian medical cannabis company. As quoted in the press release: Under the terms of the MOU, Veritas and Foliumed will jointly conduct scientific research, undertake product development activities, and commercialize select medical cannabis products with the help of Veritas’ research arm, Cannevert Therapeutics Ltd. (“CTL”). Foliumed will provide Veritas with pharma grade medical cannabis extracts derived from unique Colombian cannabis strains, manufactured in a GMP certified extraction facility. The focus of the collaboration will be aimed at advancing specific cannabis cultivars for specific disease and chronic conditions through joint Intellectual Property Development and commercialization of certain trademark medicinal products. Veritas Pharma and Foliumed Colombia aim to have products based upon Cannevert formulations produced and ready for commercial distribution in Latin America and Western Europe by Q1 2019. The product’s dosing and method of administration will be standardized to … Continue reading

Crop Receives Approval for Additional 20,000 Square Feet of Recreational Canopy at Humboldt California Campus

CROP Infrastructure Corp. (CSE:CROP) (OTCMKTS:CRXPF) (“CROP” or the “Company”) announces its tenant grower “HEMPIRE COMPANY LLC” has received final approval for an additional twenty thousand (20,000) square feet of recreationally licensed canopy space from CalCannabis Cultivation Licensing, a division of the California Department of Food and Agriculture (CDFA) for the Humboldt California Campus as announced on May 9th 2018. The Humboldt Campus consists of an operational 10,000 square foot medicinal cannabis greenhouse facility and has now obtained an additional 20,000 square feet of recreational licensed canopy. It is expected that the HEMPIRE COMPANY LLC will commence plant population in June/July 2018. CROP Infrastructure Director & CEO Michael Yorke states: “With the approval of this additional twenty thousand square feet, the Humboldt Campus will triple in size and tenant production capacity. CROP’s portfolio of cannabis infrastructure assets includes two Washington State facilities as well as the Humboldt campus in California, the largest cannabis market in the world. … Continue reading

With Cannabis Sales To Start Soon, Aurora Cannabis Is A Play You Need To Know - Seeking Alpha

With Cannabis Sales To Start Soon, Aurora Cannabis Is A Play You Need To KnowSeeking Alpha… based on the current revenues seen in Colorado. This is a large and growing market opportunity which indicates that in spite of the lofty valuations seen at CGC, ACBFF, and the other Canadian cannabis plays, there is real reason for investors to be …How Marijuana Saved a Colorado TownCivilizedFrom marijuana beer to pot cookies, Canadian companies creating cannabis edibles in anticipation of legalizationThe Globe and MailFrom marijuana beer to pot cookies, Canadian companies creating cannabis ediblesCBC.ca all 78 news articles Continue Reading … Continue reading

EXCLUSIVE: High Times IPO Shares Available Ahead of Nasdaq Listing - Cannabis Now

EXCLUSIVE: High Times IPO Shares Available Ahead of Nasdaq ListingCannabis NowThe Regulation A+ filing allows investors to buy common stock shares in the iconic cannabis media and entertainment company ahead of its planned Nasdaq stock market listing. Investors can buy one of the first cannabis-related stocks expected to go public.HIGH TIMES LAUNCHES INITIAL PUBLIC OFFERING; GIVES FANS THE OPPORTUNITY TO INVEST BEFORE THE …Markets InsiderHigh Times refreshes IPO plans as cannabis companies build buzz on Wall StreetSTLtoday.com all 16 news articles Continue Reading … Continue reading

Crop Receives Approval for Additional 20,000 Square Feet of Recreational Canopy at Humboldt California Campus

VANCOUVER, British Columbia, June 19, 2018 (GLOBE NEWSWIRE) — CROP Infrastructure Corp. (CSE:CROP) (OTCMKTS:CRXPF) (“CROP” or the “Company”) announces its tenant grower “HEMPIRE COMPANY LLC” has received final approval for an additional twenty thousand (20,000) square feet of recreationally licensed canopy space from CalCannabis Cultivation Licensing, a division of the California Department of Food and Agriculture (CDFA) for the Humboldt California Campus as announced on May 9th 2018. The Humboldt Campus consists of an operational 10,000 square foot medicinal cannabis greenhouse facility and has now obtained an additional 20,000 square feet of recreational licensed canopy. It is expected that the HEMPIRE COMPANY LLC will commence plant population in June/July 2018. CROP Infrastructure Director & CEO Michael Yorke states: “With the approval of this additional twenty thousand square feet, the Humboldt Campus will triple in size and tenant production capacity. CROP’s portfolio of cannabis infrastructure assets includes two Washington State facilities as well as the Humboldt campus in … Continue reading

Choom™ Secures 10 Additional Cannabis Retail Opportunities in Alberta and British Columbia

VANCOUVER, June 19, 2018 /CNW/ – Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the “Company” or “Choom”) an emerging, fully-integrated cannabis company, is pleased to announce that it has advanced the build-out of its cannabis retail store network in Alberta and British Columbia. Choom™ has secured the rights to an additional 7 retail locations in Alberta. Choom has 25 leases in highly strategic and secure locations in Alberta with 24 applications submitted. Choom has also secured 3 additional B.C. retail leases, combined with the existing 7, for a total of 10 retail opportunities in B.C. In all cases, the retail opportunities are subject to all necessary governmental and municipal approvals being granted. This number is expected to grow over the coming months as the Company is currently negotiating additional leases with the intention of submitting applications for retail licenses. The following link will bring you to our retail opportunity map: https://investors.choom.ca/wp-content/uploads/2017/11/ChoomRetailMap.pdf “This is a significant step towards establishing Choom’s strategy to … Continue reading

FinCanna Investee ezGreen Compliance On-Boards Multiple Customers across California, the largest Cannabis market in North America

VANCOUVER, B.C., June 19, 2018 (GLOBE NEWSWIRE) — FinCanna Capital Corp. (“FinCanna”) (CSE:CALI) (OTCQB:FNNZF) a royalty company for the U.S. licensed medical cannabis industry, announces that its portfolio investee company, ezGreen Compliance (“ezGreen”), which offers a state-of-the-art enterprise compliance and point-of-sale (POS) software solution for licensed medical cannabis dispensaries and cultivators, has launched its pilot marketing program and has on-boarded multiple customers (dispensaries and cultivators) across the State of California. The pilot program customers are currently utilizing ezGreen’s Health Insurance Portability and Accountability Act (“HIPAA”)  Compliance Point-of-Sale Solution and inventory tracking system. Navigating through state-by-state license, tax and compliance issues has been challenging for the legal cannabis industry. ezGreen Compliance helps its customers comply with both the HIPAA and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations. Andriyko Herchak, President and CEO of FinCanna, states, … Continue reading

Pascal Biosciences Engages CFN Media to Build New Investor Audience

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced that Pascal Biosciences, Inc. (TSX-V: PAS) has engaged CFN Media to conduct a 3-month investor and market visibility program to begin on June 19, 2018. “Pascal Biosciences, a Vancouver, BC and Seattle, WA-based biotechnology company, has discovered that certain cannabinoids stimulate the immune system to destroy tumor cells,” said Frank Lane, President of CFN Media. “We’re excited to be working with the company as it looks to bring its R&D-driven products to market to benefit patients.” “At Pascal, we are excited by the potential of cannabinoids for improving cancer treatment. We are looking forward to working with CFN Media to develop our investor visibility,” said Pascal Biosciences CEO and President, Dr. Patrick Gray. CFN Media will leverage its powerful content platform and extensive reach into mainstream and cannabis-focused investor … Continue reading

National Green Biomed Adopting BLOCKStrain Technology Software

VANCOUVER, June 19, 2018 /CNW/ – BLOCKStrain TECHNOLOGY CORP. (the “Company” or “BLOCKStrain“) (TSXV: DNAX) is pleased to welcome National Green Biomed Ltd. (“NG Biomed” or “NG”) to its software platform. BLOCKStrain and NG Biomed this week signed a Letter of Intent for adoption of the BLOCKStrain software platform at NG Biomed’s production facility in British Columbia, Canada. NG Biomed is a late-stage applicant to become a licensed producer under the Access to Cannabis for Medical Purposes Regulations in Canada. Under the Letter of Intent signed June 18, 2018, the Parties agree to negotiate the terms of a business relationship through which BLOCKStrain will integrate its core software platform into the operational infrastructure of NG Biomed in order to optimize product testing, genetic verification, supply chain visibility and management of grow operations. Secondly, BLOCKStrain will use its proprietary technology to create a custom platform for NG Biomed that will empower NG Biomed’s clients and partners with the ability to … Continue reading